{"id":"W4400319636","doi":"10.1080/13696998.2024.2367919","title":"The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Insulet Corporation; Gilead Sciences; Novo Nordisk; Sanofi; AstraZeneca; Eli Lilly and Company; Roche Diabetes Care; Amgen","keywords":"Medicine; Observational study; Liraglutide; Type 2 diabetes; Dulaglutide; Exenatide; Health care; Diabetes mellitus; Glucagon-like peptide 1 receptor; Real world evidence; Intensive care medicine; Internal medicine; Family medicine; Agonist; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002205638,0.0005216547,0.0005565292,0.001414907,0.0002610302,0.00136371,0.0006139679,0.0008643908,0.0009963418],"category_scores_gemma":[0.004004481,0.0003167161,0.001180562,0.002354132,0.0004004448,0.0007849045,0.00083837,0.0005650801,0.0001543975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002253338,"about_ca_system_score_gemma":0.0007079992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03629017,"about_ca_topic_score_gemma":0.02931152,"domain_scores_codex":[0.9976162,0.001211159,0.000247036,0.0003911569,0.0002690941,0.0002654116],"domain_scores_gemma":[0.9956514,0.0007583988,0.002709799,0.0001957875,0.000219086,0.0004654592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002847845,0.0000473324,0.9978057,0.00001639254,0.0002575278,0.00005902884,0.00005804837,0.0001848221,0.00002970818,0.0000264758,0.000319085,0.000911133],"study_design_scores_gemma":[0.00004473252,0.00009428323,0.9989304,0.00001383059,0.0000546827,0.00009056638,0.0001238012,0.0004360517,0.00001251536,0.00001007467,0.0001836301,0.000005388029],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969404,0.0005423654,0.00005844394,0.0001151,0.000004881728,0.00001593488,0.001991163,0.000003488085,0.0003282327],"genre_scores_gemma":[0.997166,0.0002094552,0.0001062024,0.00007445357,0.00001492777,0.00002917507,0.002296669,0.000002168631,0.0001008716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03629017,"threshold_uncertainty_score":0.07215786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03135285047652705,"score_gpt":0.3399828926197037,"score_spread":0.3086300421431767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}